Halozyme Therapeutics, Inc. (HALO)
67.70
-1.25
(-1.81%)
USD |
NASDAQ |
Dec 30, 16:00
67.51
-0.19
(-0.28%)
After-Hours: 20:00
Halozyme Therapeutics Market Cap: 7.961B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 498.51B |
| Merck & Co., Inc. | 263.24B |
| AIM ImmunoTech, Inc. | 0.9629M |
| Bristol Myers Squibb Co. | 110.36B |
| Protalix Biotherapeutics, Inc. | 139.93M |
Market Cap Related Metrics
| PE Ratio | 14.23 |
| PS Ratio | 6.838 |
| PEG Ratio | 0.2478 |
| Price to Book Value | 15.80 |
| Price to Free Cash Flow | 14.11 |
| Price | 67.70 |
| Earnings Yield | 7.03% |
| PEGY Ratio | 0.2478 |
| Operating PE Ratio | 11.52 |
| Normalized PE Ratio | 14.23 |